Filters
Early menopause or premature ovarian insufficiency may put women at increased risk of dementia, as reported in a recent study.
Acne vulgaris (acne) is one of the most common inflammatory skin conditions worldwide, with an estimated global prevalence of 9.38% across all ages. A Singaporean study found that 88% of individuals aged 13 to 19 years suffer from acne. However, acne is not solely the burden of younger patients and may afflict patients well into adulthood – 41% of adults treated at the National Skin Centre of Singapore are reported to have experienced acne since adolescence.
New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Adults with hypertension, diabetes, and cardiovascular diseases may benefit from cutting back on coffee, especially the caffeinated variant, which has been shown to increase the burden of abdominal aortic calcification in a study.
The ileal bile acid transporter (IBAT) inhibitor maralixibat appears to quell itching and reduce serum bile acid concentration in children with progressive familial intrahepatic cholestasis (PFIC), while having a tolerable safety profile, according to data from the phase III MARCH-PFIC trial said to be the largest to date.
Implementation of the mandate on preablation renal mass biopsy appears to result in the wider use of biopsies for all small renal mass patients, fewer surgical interventions, and an increase in active surveillance, reports a recent study.
Treatment with pembrolizumab (pembro) in combination with gemcitabine and cisplatin (gem/cis) results in a statistically significant, clinically meaningful improvement in overall survival (OS) when compared with placebo plus gem/cis in patients with previously untreated metastatic or unresectable biliary tract cancer (BTC), results of the KEYNOTE-966 study have shown.
Sleep disorders, particularly obstructive sleep apnoea, are associated with a higher risk of sexual dysfunction (SD) in both men and women, suggests a study.
In a pooled analysis of two long-term paediatric extension trials evaluating short bowel syndrome-associated intestinal failure (SBS-IF), the glucagon-like peptide-2 analogue teduglutide (TED) demonstrated a safety profile that aligned with previous data.
For patients with chronic kidney disease (CKD), vitamin D therapy does little to reduce the risk of all-cause death, according to a study.